CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX)

Q: What does CUSIP 23284F105 represent in this 13F holders report?

CUSIP 23284F105 is the security identifier for CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q1 2020?

113 institutional investors reported CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 23284F105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 217,291,620
Total 13F shares: 36,087,916
Share change: +95,975
Total reported value: $276,879,388
Price per share: $7.67
Number of holders: 113
Value change: +$244,869
Number of buys: 50
Number of sells: 59

Quarterly Holders Quick Answers

What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 23284F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	1.8%	4,016,048	$33,372,000	—	31 Dec 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.5%	3,253,923	$27,040,000	—	31 Dec 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.3%	2,813,451	$23,380,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	1.2%	2,689,604	$22,350,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.95%	2,063,271	$17,146,000	—	31 Dec 2019	13F
RTW INVESTMENTS, LP	13F	Company	0.48%	1,039,593	$8,639,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.46%	989,570	$8,223,000	—	31 Dec 2019	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.45%	978,862	$8,134,000	—	31 Dec 2019	13F
MPM BioImpact LLC	13F	Company	0.39%	855,437	$7,109,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.38%	828,607	$6,885,000	—	31 Dec 2019	13F
BVF INC/IL	13F	Company	0.35%	766,148	$6,367,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.34%	741,144	$6,159,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.33%	721,000	$5,992,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	702,308	$5,836,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.32%	700,101	$5,818,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.32%	686,188	$5,702,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	656,257	$5,453,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.26%	569,564	$4,733,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.26%	560,450	$4,656,000	—	31 Dec 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.22%	482,537	$4,010,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.22%	480,100	$3,990,000	—	31 Dec 2019	13F
Burrage Capital Management LLC	13F	Company	0.22%	476,110	$3,956,000	—	31 Dec 2019	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.21%	461,146	$3,832,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.2%	435,569	$3,619,000	—	31 Dec 2019	13F
EcoR1 Capital, LLC	13F	Company	0.19%	410,000	$3,407,000	—	31 Dec 2019	13F
MARSHALL WACE, LLP	13F	Company	0.18%	401,426	$3,336,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	400,455	$3,328,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.17%	369,005	$3,067,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	323,982	$2,692,000	—	31 Dec 2019	13F
Man Group plc	13F	Company	0.15%	320,655	$2,665,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.14%	310,712	$2,582,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	255,479	$2,124,000	—	31 Dec 2019	13F
Assenagon Asset Management S.A.	13F	Company	0.1%	224,640	$1,867,000	—	31 Dec 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.1%	221,059	$1,837,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.1%	212,183	$1,763,000	—	31 Dec 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.09%	203,542	$1,692,000	—	31 Dec 2019	13F
Spark Investment Management LLC	13F	Company	0.09%	203,600	$1,691,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	0.09%	194,377	$1,615,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.09%	188,647	$1,568,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	177,799	$1,476,000	—	31 Dec 2019	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.08%	175,856	$1,461,000	—	31 Dec 2019	13F
Granahan Investment Management, LLC	13F	Company	0.07%	153,818	$1,278,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.07%	148,553	$1,234,000	—	31 Dec 2019	13F
Private Advisor Group, LLC	13F	Company	0.07%	142,177	$1,181,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.06%	131,558	$1,093,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.06%	130,332	$1,083,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.06%	125,761	$1,044,000	—	31 Dec 2019	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.05%	116,516	$968,000	—	31 Dec 2019	13F
DAFNA Capital Management LLC	13F	Company	0.05%	100,000	$831,000	—	31 Dec 2019	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.05%	100,000	$831,000	—	31 Dec 2019	13F

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) as of Q1 2020

As of 31 Mar 2020, CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,087,916 shares. The largest 10 holders included BlackRock Inc., BVF INC/IL, PERCEPTIVE ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, RTW INVESTMENTS, LP, STATE STREET CORP, MPM ONCOLOGY IMPACT MANAGEMENT LP, and FMR LLC. This page lists 113 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

119

Q1 2020 holders

113

Holder diff

-6

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.